Cargando…
Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset
We present a 76-year-old man who visited our center because of persistent dyspnea with hypoxia on exertion 6 months after onset of coronavirus disease 2019. Chest computed tomography showed bilateral extensive subpleural reticulation with traction bronchiectasis predominantly in the lower lung lobes...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234020/ http://dx.doi.org/10.1016/j.hpr.2022.300666 |
_version_ | 1784735959321935872 |
---|---|
author | Muto, Yutaka Okudela, Koji Nakazawa, Atsuhito Hisakane, Kakeru Matsumura, Mai Takemura, Tamiko Iwasawa, Tae Ogura, Takashi |
author_facet | Muto, Yutaka Okudela, Koji Nakazawa, Atsuhito Hisakane, Kakeru Matsumura, Mai Takemura, Tamiko Iwasawa, Tae Ogura, Takashi |
author_sort | Muto, Yutaka |
collection | PubMed |
description | We present a 76-year-old man who visited our center because of persistent dyspnea with hypoxia on exertion 6 months after onset of coronavirus disease 2019. Chest computed tomography showed bilateral extensive subpleural reticulation with traction bronchiectasis predominantly in the lower lung lobes. Transbronchial lung cryobiopsy revealed spatially and temporally intermittent interstitial fibrosis with mild lymphoid cell infiltration. Not only were there membranous fibrotic scars on the alveolar septa, but there were scattered foci of alveolar collapse with young fibroblastic proliferations, suggesting progressive interstitial fibrotic lesions. In addition to fibrotic phase of diffuse alveolar damage, the acceleration of subclinical preexisting interstitial lung abnormalities might have affected his respiratory condition. |
format | Online Article Text |
id | pubmed-9234020 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92340202022-06-27 Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset Muto, Yutaka Okudela, Koji Nakazawa, Atsuhito Hisakane, Kakeru Matsumura, Mai Takemura, Tamiko Iwasawa, Tae Ogura, Takashi Human Pathology Reports Article We present a 76-year-old man who visited our center because of persistent dyspnea with hypoxia on exertion 6 months after onset of coronavirus disease 2019. Chest computed tomography showed bilateral extensive subpleural reticulation with traction bronchiectasis predominantly in the lower lung lobes. Transbronchial lung cryobiopsy revealed spatially and temporally intermittent interstitial fibrosis with mild lymphoid cell infiltration. Not only were there membranous fibrotic scars on the alveolar septa, but there were scattered foci of alveolar collapse with young fibroblastic proliferations, suggesting progressive interstitial fibrotic lesions. In addition to fibrotic phase of diffuse alveolar damage, the acceleration of subclinical preexisting interstitial lung abnormalities might have affected his respiratory condition. The Authors. Published by Elsevier Inc. 2022-09 2022-06-27 /pmc/articles/PMC9234020/ http://dx.doi.org/10.1016/j.hpr.2022.300666 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Muto, Yutaka Okudela, Koji Nakazawa, Atsuhito Hisakane, Kakeru Matsumura, Mai Takemura, Tamiko Iwasawa, Tae Ogura, Takashi Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset |
title | Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset |
title_full | Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset |
title_fullStr | Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset |
title_full_unstemmed | Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset |
title_short | Active pulmonary interstitial fibrosis in a COVID-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset |
title_sort | active pulmonary interstitial fibrosis in a covid-19 survivor diagnosed by transbronchial lung cryobiopsy six months after onset |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234020/ http://dx.doi.org/10.1016/j.hpr.2022.300666 |
work_keys_str_mv | AT mutoyutaka activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset AT okudelakoji activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset AT nakazawaatsuhito activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset AT hisakanekakeru activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset AT matsumuramai activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset AT takemuratamiko activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset AT iwasawatae activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset AT oguratakashi activepulmonaryinterstitialfibrosisinacovid19survivordiagnosedbytransbronchiallungcryobiopsysixmonthsafteronset |